Connection

Mark Hamner to Attention Deficit Disorder with Hyperactivity

This is a "connection" page, showing publications Mark Hamner has written about Attention Deficit Disorder with Hyperactivity.
  1. Atomoxetine in comorbid ADHD/PTSD: A randomized, placebo controlled, pilot, and feasibility study. Depress Anxiety. 2022 04; 39(4):286-295.
    View in: PubMed
    Score: 0.666
  2. Cue-dependent inhibition in posttraumatic stress disorder and attention-deficit/hyperactivity disorder. J Anxiety Disord. 2017 Oct; 51:1-6.
    View in: PubMed
    Score: 0.121
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.